Cargando…

Generation of three induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying MYH7 mutations

MYH7 heterozygous mutations are common genetic causes of hypertrophic cardiomyopathy (HCM). HCM is characterized by hypertrophy of the left ventricle and diastolic dysfunction. We generated three human induced pluripotent stem cell (iPSC) lines from three HCM patients each carrying a single heterozy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Xu, Jahng, James W.S., Lee, Chelsea, Zha, Yanjun, Wheeler, Matthew T., Sallam, Karim, Wu, Joseph C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339835/ https://www.ncbi.nlm.nih.gov/pubmed/34352619 http://dx.doi.org/10.1016/j.scr.2021.102455

Ejemplares similares

Generation of three induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying TNNI3 mutations
por: Zhao, Shane Rui, et al.
Publicado: (2021)

Generation of two iPSC lines from hypertrophic cardiomyopathy patients carrying MYBPC3 and PRKAG2 variants
por: Manhas, Amit, et al.
Publicado: (2022)

Genetic variations of β-MYH7 in hypertrophic cardiomyopathy and dilated cardiomyopathy
por: Tanjore, Reena, et al.
Publicado: (2010)

Generation of two heterozygous MYBPC3 mutation-carrying human iPSC lines, SCVIi001-A and SCVIi002-A, for modeling hypertrophic cardiomyopathy
por: Liu, Lichao, et al.
Publicado: (2021)

Myocardial Deformation Analysis in MYBPC3 and MYH7 Related Sarcomeric Hypertrophic Cardiomyopathy—The Graz Hypertrophic Cardiomyopathy Registry
por: Höller, Viktoria, et al.
Publicado: (2021)

Generation of two induced pluripotent stem cell lines carrying the phospholamban R14del mutation for modeling ARVD/C
por: Vera, Carlos D., et al.
Publicado: (2022)

End-stage Hypertrophic Cardiomyopathy with Advanced Heart Failure in Patients Carrying MYH7 R453 Variants: A Case Series
por: Naito, Susumu, et al.
Publicado: (2023)

Screening of MYH7 gene mutation sites in hypertrophic cardiomyopathy and its significance
por: Liu, Hui-Ting, et al.
Publicado: (2019)

Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying TTN mutations
por: Zhang, Tina Tianbo, et al.
Publicado: (2022)

Intrauterine Treatment of a Fetus with Familial Hypertrophic Cardiomyopathy Secondary to MYH7 Mutation
por: Hill, Meghan G., et al.
Publicado: (2015)

Genetic analysis of monoallelic double MYH7 mutations responsible for familial hypertrophic cardiomyopathy
por: Wang, Bo, et al.
Publicado: (2019)

Severe hypertrophic cardiomyopathy in a patient with a homozygous MYH7 gene variant
por: Serra, Walter, et al.
Publicado: (2022)

Generation of three induced pluripotent stem cell lines, SCVIi003-A, SCVIi004-A, SCVIi005-A, from patients with ARVD/C caused by heterozygous mutations in the PKP2 gene
por: Jahng, James W.S., et al.
Publicado: (2021)

Intrinsic MYH7 expression regulation contributes to tissue level allelic imbalance in hypertrophic cardiomyopathy
por: Montag, Judith, et al.
Publicado: (2017)

Variation p.R1045H in MYH7 correlated with hypertrophic cardiomyopathy in a Chinese pedigree
por: Zhang, Yan, et al.
Publicado: (2021)

Genotype-Phenotype Correlation in Hypertrophic Cardiomyopathy: New Variant p.Arg652Lys in MYH7
por: Antoniutti, Guido, et al.
Publicado: (2022)

Whole-exome sequencing reveals MYH7 p.R671C mutation in three different phenotypes of familial hypertrophic cardiomyopathy
por: Yu, Wei, et al.
Publicado: (2021)

Generation of three iPSC lines from dilated cardiomyopathy patients carrying a pathogenic LMNA variant
por: Lee, Chelsea, et al.
Publicado: (2022)

Heterozygous LMNA mutation-carrying iPSC lines from three cardiac laminopathy patients
por: Cho, Sangkyun, et al.
Publicado: (2022)

The contribution of mutations in MYH7 to the onset of cardiomyopathy
por: Bollen, I. A. E., et al.
Publicado: (2017)

Successful knock-in of Hypertrophic Cardiomyopathy-mutation R723G into the MYH7 gene mimics HCM pathology in pigs
por: Montag, J., et al.
Publicado: (2018)

Circulating miR-499a-5p Is a Potential Biomarker of MYH7—Associated Hypertrophic Cardiomyopathy
por: Baulina, Natalia, et al.
Publicado: (2022)

Cardiomyocyte apoptosis contributes to contractile dysfunction in stem cell model of MYH7 E848G hypertrophic cardiomyopathy
por: Loiben, Alexander M., et al.
Publicado: (2023)

Cardiomyocyte Apoptosis Is Associated with Contractile Dysfunction in Stem Cell Model of MYH7 E848G Hypertrophic Cardiomyopathy
por: Loiben, Alexander M., et al.
Publicado: (2023)

Generation of human induced pluripotent stem cell lines carrying heterozygous PLN mutation from dilated cardiomyopathy patients
por: Caudal, Arianne, et al.
Publicado: (2022)

Burst-Like Transcription of Mutant and Wildtype MYH7-Alleles as Possible Origin of Cell-to-Cell Contractile Imbalance in Hypertrophic Cardiomyopathy
por: Montag, Judith, et al.
Publicado: (2018)

Phenotypic diversity identified by cardiac magnetic resonance in a large hypertrophic cardiomyopathy family with a single MYH7 mutation
por: Wang, Jie, et al.
Publicado: (2018)

MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onset
por: Marsili, Luisa, et al.
Publicado: (2023)

A Family with Myh7 Mutation and Different Forms of Cardiomyopathies
por: Catrina, Bianca Iulia, et al.
Publicado: (2023)

Genetic Clues on Implantable Cardioverter-Defibrillator Placement in Young-Age Hypertrophic Cardiomyopathy: A Case Report of Novel MYH7 Mutation and Literature Review
por: Li, Xing, et al.
Publicado: (2021)

Novel Adult-Onset Systolic Cardiomyopathy Due to MYH7 E848G Mutation in Patient-Derived Induced Pluripotent Stem Cells
por: Yang, Kai-Chun, et al.
Publicado: (2018)

Novel Mutations in β-MYH7 Gene in Indian Patients With Dilated Cardiomyopathy
por: Rani, Deepa Selvi, et al.
Publicado: (2021)

Inhibition of mTOR or MAPK ameliorates vmhcl/myh7 cardiomyopathy in zebrafish
por: Bu, Haisong, et al.
Publicado: (2021)

Prevalence and Phenotypic Expression of Mutations in the MYH7, MYBPC3 and TNNT2 Genes in Families with Hypertrophic Cardiomyopathy in the South of Brazil: A Cross-Sectional Study
por: Mattos, Beatriz Piva e, et al.
Publicado: (2016)

Generation and characterization of a Myh6-driven Cre knockin mouse line
por: Huang, Xinyan, et al.
Publicado: (2021)

Identification of MYH6 as the potential gene for human ischaemic cardiomyopathy
por: Chen, Jian‐Hong, et al.
Publicado: (2021)

Digenic Inheritance of LAMA4 and MYH7 Mutations in Patient with Infantile Dilated Cardiomyopathy
por: Abdallah, Atiyeh M, et al.
Publicado: (2019)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells
por: Han, Lu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_uqv0r963jfdi9lpdp8revon41f